Catherine DeVoe
Impact in
- Infectious Diseases top 10%
- COVID-19 Clinical Research Studies
- Antifungal resistance and susceptibility
- SARS-CoV-2 and COVID-19 Research
Papers in ⓘ
-
- Antifungal resistance and susceptibility 3
- COVID-19 Clinical Research Studies 3
- SARS-CoV-2 and COVID-19 Research 2
- Oncology 5
- Neutropenia and Cancer Infections 4
- Co-authors
- John E. Conte (2 shared papers)Jeffrey A. Golden (2 shared papers)Emily Little (1 shared paper)Monica Fung (6 shared papers)Deborah S. Yokoe (4 shared papers)Jennifer M. Babik (4 shared papers)Peter Chin‐Hong (5 shared papers)Sarah B. Doernberg (5 shared papers)
- Journals
- Open Forum Infectious Diseases (4 papers)Antimicrobial Agents and Chemotherapy (2 papers)Infection Control and Hospital Epidemiology (2 papers)Gastroenterology (1 paper)Clinical Cancer Research (1 paper)
- Partner nations
- United StatesFrance
In The Last Decade
Catherine DeVoe
12 papers receiving 271 citations
Peers
Comparison fields: 5 of 56
- Applied Microbiology and Biotechnology 25
- Infectious Diseases 175
- Obstetrics and Gynecology 38
- Oncology 75
- Epidemiology 89
Countries citing papers authored by Catherine DeVoe
This map shows the geographic impact of Catherine DeVoe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Catherine DeVoe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Catherine DeVoe more than expected).
Fields of papers citing papers by Catherine DeVoe
This network shows the impact of papers produced by Catherine DeVoe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Catherine DeVoe. The network helps show where Catherine DeVoe may publish in the future.
Co-authors
The 25 scholars most cited alongside Catherine DeVoe, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 54 | |
| 2 | 2013 | 54 | |
| 3 | 2020 | 39 | |
| 4 | 2010 | 36 | |
| 5 | 2010 | 36 | |
| 6 | 2021 | 34 | |
| 7 | 2022 | 9 | |
| 8 | 2022 | 4 | |
| 9 | 2021 | 4 | |
| 10 | 2024 | 2 | |
| 11 | 2018 | 2 | |
| 12 | 2012 | 1 | |
| 13 | 2019 | 0 |
About Catherine DeVoe
Catherine DeVoe is a scholar working on Infectious Diseases, Oncology, Epidemiology, Obstetrics and Gynecology and Genetics, having authored 13 papers that have together received 275 indexed citations. Recurring topics across this work include Neutropenia and Cancer Infections (4 papers), Antifungal resistance and susceptibility (3 papers), COVID-19 Clinical Research Studies (3 papers), Cancer Genomics and Diagnostics (2 papers), SARS-CoV-2 and COVID-19 Research (2 papers), COVID-19 Impact on Reproduction (2 papers), Fungal Infections and Studies (2 papers) and Mycobacterium research and diagnosis (1 paper). The work is most often cited by research in Applied Microbiology and Biotechnology (25 citations), Infectious Diseases (175 citations), Obstetrics and Gynecology (38 citations), Oncology (75 citations) and Epidemiology (89 citations). Catherine DeVoe has collaborated with scholars based in United States and France. Frequent co-authors include John E. Conte, Jeffrey A. Golden, Emily Little, Monica Fung, Deborah S. Yokoe, Jennifer M. Babik, Peter Chin‐Hong, Sarah B. Doernberg, Emma Bainbridge and Charles Langelier. Their work appears in journals such as Open Forum Infectious Diseases, Antimicrobial Agents and Chemotherapy, Infection Control and Hospital Epidemiology, Gastroenterology and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.